Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
506
-
Total 13F shares, excl. options
-
109M
-
Shares change
-
+456K
-
Total reported value, excl. options
-
$8B
-
Value change
-
-$8.99M
-
Put/Call ratio
-
0.32
-
Number of buys
-
289
-
Number of sells
-
-210
-
Price
-
$73.20
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2025
590 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2025.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 506 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109M shares
of 115M outstanding shares and own 94.86% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.9M shares), BlackRock, Inc. (10.7M shares), JANUS HENDERSON GROUP PLC (7.01M shares), STATE STREET CORP (3.62M shares), Burgundy Asset Management Ltd. (2.8M shares), JPMORGAN CHASE & CO (2.63M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.27M shares), Sculptor Capital LP (2.09M shares), GEODE CAPITAL MANAGEMENT, LLC (2.03M shares), and Invesco Ltd. (2.02M shares).
This table shows the top 506 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.